Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: “Real World” Data From Germany
暂无分享,去创建一个
L. Bullinger | K. Götze | F. Bassermann | P. Kiewe | M. Verbeek | I. Bumeder | J. Westermann | J. Krönke | K. Rieger | L. Schmalbrock | U. Keller | Krischan Braitsch | J. Hecker | P. Jung